Analyse fonctionnelle de la polycystine-1 et de son domaine intracellulaire dans le développement de la polykystose rénale autosomique dominante
Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder affecting 1:500 people worldwide, independently from sex and origin. ADPKD is characterized by formation of large bilateral kidney cysts affecting all segments of the nephron and increasing progressively in size and number leading to end stage renal failure by mid-fifty. Moreover, this systemic disease includes several extrarenal symptoms such as intracranial aneurysms, valvular defects and cysts formation in the liver and the pancreas. PKD1 and PKD2 genes mutations are involved in 85 and 15 % of the clinical cases. PKD genes encode polycystin-1 (PC-1) and -2 (PC-2), which both form a complex at the cell and ciliary membrane of renal epithelial cells. PC-1 is a large transmembrane protein with a small intracellular tail including a coiled-coil motif implicated in PC-1/PC-2 interaction in-vitro. Interestingly, specific mutations affecting the coiled-coil motif cause ADPKD in humans. The pathogenetic mechanism of ADPKD is unknown. In mice, both ablation (Pkd1-/-) or overexpression (SBPkd1TAG) of Pkd1 cause ADPKD, suggesting a dosage model. Ciliary anomalies are also linked to polycystic kidney disease. Herein, we evaluated in-vivo the role of Pkd1 in the development of renal and extrarenal manifestations of ADPKD and more specifically, the role of the coiled-coil motif in cystogenesis. We generated two constructions, wildtype Pkd1 (Pkd1TAG) and coiled-coil deleted Pkd1 (Pkd1ΔCoiled-coil), by homologous recombination from the wildtype Pkd1-BAC comprising the whole Pkd1 murine sequence. Three Pkd1TAG mice lines have been generated by microinjection and show expression patterns correlating with the copy number of the transgene (2, 5 and 15 copy). All Pkd1TAG mice develop renal cysts affecting all nephron segments as in ADPKD and longer primary cilia compared to wildtype mice. Physiologic analysis supports renal failure by increased urinary output and decreased of urinary proteins, osmolality and creatinin levels. Pkd1TAG mice also show cysts in the liver, cardiac and valvular anomalies associated with calcium deposition and cerebral aneurysms. The severity of the phenotype increased with Pkd1 expression suggesting a dosage model. Importantly, the Pkd1TAG transgene rescue embryonic lethality of Pkd1-/- mice. Furthermore, we generated 4 lines of Pkd1ΔCoiled-coil mice of 2 and 15 copies of the transgene correlating also to the level of expression. Compared to age-matched Pkd1TAG, Pkd1ΔCoiled-coil mice develop no cysts and show normal cilia length. To gain more insights on the role of coiled-coil motif in absence of endogenous Pc-1, we mated Pkd1ΔCoiled-coil with Pkd1-/- mice. Compared to the lethal embryonic Pkd1-/- mice, Pkd1ΔCoiled-coil; Pkd1-/- live ~ 10 to 14 days. They show severe renal and pancreatic cysts as well as growth retardation and pulmonary defects. My study demonstrates that Pkd1 overexpression is a pathogenic mechanism to induce ADPKD renal and extrarenal phenotype. Moreover, this work shows that the coiled-coil motif of polycystin-1 is a critical determinant in ADPKD cystogenesis.
Adpkd Pkd1 Coiled-coil Cystogenesis